Lilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy

Group 1 - Eli Lilly has established itself as the market leader in obesity drugs across Europe, Asia, and the Middle East [1] - The company expects to replicate its U.S. dominance in the global market [1]